Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?
about
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's diseaseThe gut mucosal immune response to Toxoplasma gondiiNucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitisPituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelaeDissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal ModelsToxoplasma gondii oral infection induces intestinal inflammation and retinochoroiditis in mice genetically selected for immune oral tolerance resistanceThe myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 productionSelection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in miceIntestinal, extra-intestinal and systemic sequelae of Toxoplasma gondii induced acute ileitis in mice harboring a human gut microbiota.Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infectionThe impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis.Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya.CCR2-dependent intraepithelial lymphocytes mediate inflammatory gut pathology during Toxoplasma gondii infectionmiR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.Modulation of innate immunity by Toxoplasma gondii virulence effectors.MIF participates in Toxoplasma gondii-induced pathology following oral infection.CCR5 controls immune and metabolic functions during Toxoplasma gondii infectionEpidemiology of and diagnostic strategies for toxoplasmosisAnti-gluten immune response following Toxoplasma gondii infection in miceGastrointestinal inflammation and associated immune activation in schizophrenia.Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection.Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunityBorder maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.Innate responses to Toxoplasma gondii in mice and humansSynergy between intraepithelial lymphocytes and lamina propria T cells drives intestinal inflammation during infection.Interferon-Gamma Release Assay: An Effective Tool to Detect Early Toxoplasma gondii Infection in Mice.Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice.Regulatory role of suppressive motifs from commensal DNA.Cytokine regulation of immunopathology in toxoplasmosis.CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortalityRegulation of toll-like receptors in intestinal epithelial cells by stress and Toxoplasma gondii infectionGr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.Blockade of IL-1R signaling diminishes Paneth cell depletion and Toxoplasma gondii induced ileitis in mice.Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii.Colonization resistance against genetically modified Escherichia coli K12 (W3110) strains is abrogated following broad-spectrum antibiotic treatment and acute ileitis.
P2860
Q21560778-17E31612-EEC0-49DD-A768-7AF3F608BD3BQ26863747-14754190-71DD-4579-BC0C-474B3E573BA9Q27314835-07C4E6D6-CDE0-48E0-B6E7-42B3192C7E0CQ27345033-5F3B6A3F-C512-4286-BD2C-AA587B89849BQ28072332-016DF5E2-952D-41EA-BF31-DF5BA2036DA9Q28542376-E29428D8-2D9D-4E7C-9F96-0908368E4C01Q28730911-76E5B649-0B9B-4990-9680-DCA3F5A67129Q33415462-1D8E0F5D-825B-4D91-B4A3-17A963D63345Q33570901-380855EF-0DF9-4557-BB8B-5D6670108F76Q33590409-E45A772A-D591-43C6-98FB-0B5DE731FDE6Q33624096-7E9C187C-C0FB-4481-9089-3581DE0FD638Q33756071-50F990F7-1250-4CD9-967E-54CE2C846F48Q33769533-6B9060D7-CCCE-4D1C-B417-5F680F94263BQ33775618-30CF7831-D2C1-4F72-8FBA-95E62550B368Q33815140-01AA067A-2E73-4620-9320-5674F133D940Q33882867-D92ED7D9-0863-4F79-9D0C-023E3E2DB3D6Q33901336-A8F89996-17E7-42DB-8E54-8708056BBA9DQ34033981-AEB78845-3562-4F21-B8D5-B81F64C18AADQ34041592-619A0592-EF5F-44AE-B0E6-656CA107C494Q34041961-70DBB3AA-7175-4E22-88E0-7D8B8F4CB5D6Q34267180-9624AFDC-1A2F-4777-8C38-EB431295CBEFQ34500800-CEAF41F6-C4F8-446F-8A64-1B2932A0B8BAQ34574957-E0DAF1D6-4DAA-4166-96D8-10099C4A4520Q34759357-81DB0A7F-D364-491F-AD0F-E1E967A1DF0DQ35088408-5AEBD5FE-6243-45F0-9552-5BC92154A390Q35143581-55E4EB9C-E8DC-4FD3-9F61-F8EE8D8D0BE1Q35175437-DC304D2A-ED0B-4926-9295-8E5825F9464EQ35388218-B903B45E-7248-4931-9601-DE2D376C9275Q35778354-6FE6B319-B440-4096-A2D7-25F480FED5B5Q36139460-FE02079C-9DAC-41F4-B02D-2E7525703039Q36189322-44B70DDD-31C8-4A2F-B70A-A82052D0B2ABQ36709991-098CF3CF-256E-4E4E-980D-CEB957673141Q36855774-0961FF83-638D-45C7-BFF4-A060D06B7C78Q36931850-9B5E9534-8B88-4EDC-AB5A-E014B28D7FA1Q37013088-168D5F03-037A-4D3D-92EA-C8FC47312E99Q37020098-2BF8627C-1C6A-4092-B1B3-2BCC533519E8Q37021696-54C1FAE1-11A3-46D2-86E3-1DE5D44D35E7Q37320010-7CB4E91B-378D-4754-9148-174C46A19C8BQ37320024-87DC18BB-3899-428E-8256-F61C279E5107Q37320039-AD1243B1-D190-4D33-93C2-335D0E36D204
P2860
Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@ast
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@en
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@nl
type
label
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@ast
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@en
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@nl
prefLabel
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@ast
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@en
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@nl
P921
P356
P1476
Oral infection of C57BL/6 mice ...... of inflammatory bowel disease?
@en
P2093
Oliver Liesenfeld
P304
P356
10.1086/338006
P407
P478
185 Suppl 1
P577
2002-02-01T00:00:00Z